Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours

被引：0
|
作者：
Hallet, Julie [1 ,2 ]
Soreide, Kjetil [3 ,4 ,5 ]
机构：
[1] Univ Toronto, Dept Surg, 2075 Bayview Ave,T2-102, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Div Surg Oncol, Susan Leslie Clin Neuroendocrine Tumours, Toronto, ON, Canada
[3] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway
[4] Stavanger Univ Hosp, Lab Mol Med, Gastrointestinal Translat Res Grp, Stavanger, Norway
[5] Univ Bergen, Dept Clin Med, Bergen, Norway
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷 / 09期
关键词：
D O I：
10.1093/bjs/znae183
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
    Starr, Jason S.
    Sonbol, Mohamad Bassam
    Hobday, Timothy J.
    Sharma, Akash
    Kendi, Ayse Tuba
    Halfdanarson, Thorvardur R.
    ONCOTARGETS AND THERAPY, 2020, 13 : 3545 - 3555
  • [42] Lutetium-177 Dotatate peptide receptor radionuclide therapy outcomes for neuroendocrine tumours
    AlHilali, M.
    Carberry, J.
    Challis, A.
    Atherton, P.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1095 - S1096
  • [43] Peptide Receptor Radionuclide Therapy In Broncopulmonary Neuroendocrine Tumours - Results Of A Single Centre Experience
    Ferreira, G.
    Castro, S.
    Costa, C.
    Violante, L.
    Teixeira, J.
    Duarte, H.
    Sampaio, I. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S89 - S89
  • [44] Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy
    Bodei, Lisa
    Schoeder, Heiko
    Baum, Richard P.
    Herrmann, Ken
    Strosberg, Jonathan
    Caplin, Martyn
    Oeberg, Kjell
    Modlin, Irvin M.
    LANCET ONCOLOGY, 2020, 21 (09): : E431 - E443
  • [45] Dose response of pancreatic neuroendocrine tumours treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE
    Ilan, E.
    Sandstrom, M.
    Garske-Roman, U.
    Sundin, A.
    Wassberg, C.
    Lubberink, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S223 - S224
  • [46] A dosimetric comparison of systemic peptide receptor radionuclide therapy and intra-arterial peptide receptor radionuclide therapy in patients with liver dominant gastroenteropancreatic neuroendocrine tumours
    Nautiyal, Amit
    Jha, Ashish K.
    Konuparamban, Acsah
    Mithun, Sneha
    Srichandan, Tusharkanta
    Puranik, Ameya
    Gala, Kunal
    Shetty, Nithin
    Kulkarni, Suyash
    Rangarajan, Venkatesh
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (07) : 585 - 595
  • [47] Surgery, Liver Directed Therapy and Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumor Liver Metastases
    Ngongoni, Rejoice
    Visser, Brendan
    CANCERS, 2022, 14 (20)
  • [48] Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
    Kwekkeboom, Dik J.
    Krenning, Eric P.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) : 179 - +
  • [49] Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
    Bodei, Lisa
    Cremonesi, Marta
    Kidd, Mark
    Grana, Chiara M.
    Severi, Stefano
    Modlin, Irvin M.
    Paganelli, Giovanni
    THORACIC SURGERY CLINICS, 2014, 24 (03) : 333 - +
  • [50] Cure of Neuroendocrine Carcinoma by Peptide Receptor Radionuclide Therapy
    Zoephel, Klaus
    Strumpf, Annette
    Wunderlich, Gerd
    Oehme, Liane
    Eisenhofer, Graeme
    Kotzerke, Joerg
    CLINICAL NUCLEAR MEDICINE, 2008, 33 (10) : 690 - 691
12345